Charles River Laboratories International, Inc. (CRL)
Market Cap | 10.23B |
Revenue (ttm) | 4.18B |
Net Income (ttm) | 484.03M |
Shares Out | 51.27M |
EPS (ttm) | 9.43 |
PE Ratio | 21.17 |
Forward PE | 18.37 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 751,771 |
Open | 196.07 |
Previous Close | 198.15 |
Day's Range | 192.40 - 202.78 |
52-Week Range | 181.22 - 262.00 |
Beta | 1.33 |
Analysts | Buy |
Price Target | 237.10 (+18.78%) |
Earnings Date | Nov 1, 2023 |
About CRL
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provi... [Read more]
Financial Performance
In 2022, CRL's revenue was $3.98 billion, an increase of 12.31% compared to the previous year's $3.54 billion. Earnings were $486.23 million, an increase of 24.36%.
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for CRL stock is "Buy." The 12-month stock price forecast is $237.1, which is an increase of 18.78% from the latest price.
News

Charles River Laboratories to Host Virtual Investor Day
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories to Host Investor Day on September 21, 2023.

Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica
WILMINGTON, Mass. & DENVER--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River and Related Sciences announced a multi-program collaboration to apply Logica across several previously undrugged targets.

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories to Present at September Conferences.

Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods
WILMINGTON, Mass. & PARIS--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and PathoQuest SAS, a leader in the development and provision of next-generation sequencing (NGS)...

Thailand's Government Pension Fund Selects Charles River for Managing Their Front Office Operations
BANGKOK--(BUSINESS WIRE)-- #assetowner--Thailand's Government Pension Fund (GPF) has selected Charles River IMS to modernise their front office operations.

Charles River Lab signs joint agreement for protection of crabs used in medical tests
Charles River Laboratories has signed a joint agreement with four entities to enhance protections in South Carolina for horseshoe crabs and a bird that feeds on their eggs, they said on Thursday.

Charles River Laboratories Announces Plasmid Manufacturing Collaboration with Fondazione Telethon
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL), today announced a High Quality (HQ) plasmid manufacturing collaboration with Fondazione Telethon. The ra...

CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Charles River Laboratories International, In...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Charles River Laboratories International, Inc. (NYSE: CRL)
NEW YORK , Aug. 21, 2023 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Charles River Laboratories International, Inc. (NYSE: CRL) concerning possible breaches of...

Charles River beats quarterly estimates on firm demand for drug discovery services
Charles River Laboratories International beat Wall Street estimates for second-quarter profit and revenue on Wednesday, boosted by strong demand for its services that help clients discover new drug ca...

Charles River Laboratories Announces Second-Quarter 2023 Results
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories Announces Second-Quarter 2023 Results.

Charles River Laboratories International (CRL): A Significantly Undervalued Gem?
With a daily gain of 3.46% and an Earnings Per Share (EPS) of 9.67, Charles River Laboratories International Inc ( CRL , Financial) has presented an intriguing question to value investors: Is the stoc...

Charles River Laboratories Expands Access to AAALAC-Accredited, Turnkey Research Space in Key Markets
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River announces the expansion of CRADL® in Seattle and Philadelphia, growing contract vivarium space for the biopharmaceutical industry.

Rathbone Funds Now Live on Charles River IMS® and State Street Alpha® Data Platform
LONDON--(BUSINESS WIRE)-- #assetmanagement--Charles River Development, a State Street Company, today announced that Rathbone Funds (Rathbone Unit Trust Management Ltd), the London-based subsidiary of ...

Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call.

CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
NEW YORK , July 18, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CR...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
NEW YORK , July 17, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL). ...

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming July 18, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors...

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Charles River Investors of a Lead Plaintiff Deadline of July 18, 2023
NEW YORK , July 17, 2023 /PRNewswire/ -- Attention Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL) shareholders: The Law Offices of Vincent Wong announce that a class acti...

Kessler Topaz Meltzer & Check, LLP Notifies Charles River Laboratories International, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
RADNOR, Pa. , July 16, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been against Charles River L...

CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit
BENSALEM, Pa. , July 14, 2023 /PRNewswire/ -- Law Offices of Howard G.

CRL SHAREHOLDER ALERT: Jakubowitz Law Reminds Charles River Shareholders of a Lead Plaintiff Deadline of July 18, 2023
NEW YORK , July 14, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Charles River Laboratories International, Inc....

CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK , July 13, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) of a class action sec...

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Charles River Laboratories International, Inc. - CRL
CEDARHURST, N.Y. , July 12, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Charles River Laboratories International, Inc. (NYSE: CRL)...